Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Front Public Health ; 11: 1090474, 2023.
Article in English | MEDLINE | ID: covidwho-2241179

ABSTRACT

Objective: Climate and environmental change is a well-known factor causing bronchial asthma in children. After the outbreak of coronavirus disease (COVID-19), climate and environmental changes have occurred. The present study investigated the relationship between climate changes (meteorological and environmental factors) and the number of hospitalizations for pediatric bronchial asthma in Suzhou before and after the COVID-19 pandemic. Methods: From 2017 to 2021, data on daily inpatients diagnosed with bronchial asthma at Children's Hospital of Soochow University were collected. Suzhou Meteorological and Environmental Protection Bureau provided daily meteorological and environmental data. To assess the relationship between bronchial asthma-related hospitalizations and meteorological and environmental factors, partial correlation and multiple stepwise regression analyses were used. To estimate the effects of meteorological and environmental variables on the development of bronchial asthma in children, the autoregressive integrated moving average (ARIMA) model was used. Results: After the COVID-19 outbreak, both the rate of acute exacerbation of bronchial asthma and the infection rate of pathogenic respiratory syncytial virus decreased, whereas the proportion of school-aged children and the infection rate of human rhinovirus increased. After the pandemic, the incidence of an acute asthma attack was negatively correlated with monthly mean temperature and positively correlated with PM2.5. Stepwise regression analysis showed that monthly mean temperature and O3 were independent covariates (risk factors) for the rate of acute asthma exacerbations. The ARIMA (1, 0, 0) (0, 0, 0) 12 model can be used to predict temperature changes associated with bronchial asthma. Conclusion: Meteorological and environmental factors are related to bronchial asthma development in children. The influence of meteorological and environmental factors on bronchial asthma may be helpful in predicting the incidence and attack rates.


Subject(s)
Asthma , COVID-19 , Child , Humans , Pandemics , COVID-19/epidemiology , Asthma/epidemiology , Incidence , Hospitalization
2.
Nat Commun ; 14(1): 223, 2023 01 14.
Article in English | MEDLINE | ID: covidwho-2185846

ABSTRACT

Consistent annotation transfer from reference dataset to query dataset is fundamental to the development and reproducibility of single-cell research. Compared with traditional annotation methods, deep learning based methods are faster and more automated. A series of useful single cell analysis tools based on autoencoder architecture have been developed but these struggle to strike a balance between depth and interpretability. Here, we present TOSICA, a multi-head self-attention deep learning model based on Transformer that enables interpretable cell type annotation using biologically understandable entities, such as pathways or regulons. We show that TOSICA achieves fast and accurate one-stop annotation and batch-insensitive integration while providing biologically interpretable insights for understanding cellular behavior during development and disease progressions. We demonstrate TOSICA's advantages by applying it to scRNA-seq data of tumor-infiltrating immune cells, and CD14+ monocytes in COVID-19 to reveal rare cell types, heterogeneity and dynamic trajectories associated with disease progression and severity.


Subject(s)
COVID-19 , Humans , Reproducibility of Results , Single-Cell Analysis/methods , Disease Progression , Exome Sequencing , Sequence Analysis, RNA/methods
3.
Indoor Air ; 32(8): e13099, 2022 08.
Article in English | MEDLINE | ID: covidwho-2005271

ABSTRACT

Particle size removal efficiencies for 0.1-1.0 µm ( PSE 0.1 - 1.0 $$ {PSE}_{0.1-1.0} $$ ) and 0.3-1.0 µm ( PSE 0.3 - 1.0 $$ {PSE}_{0.3-1.0} $$ ) diameter of Minimum Efficiency Reporting Value (MERV) filters, an electrostatic enhanced air filter (EEAF), and their two-stage filtration systems were evaluated. Considering the most penetrating particle size was 0.1-0.4 µm particulate matter (PM), the PSE 0.1 - 1.0 $$ {PSE}_{0.1-1.0} $$ as an evaluation parameter deserves more attention during the COVID-19 pandemic, compared to the PSE 0.3 - 1.0 $$ {PSE}_{0.3-1.0} $$ . The MERV 13 filters were recommended for a single-stage filtration system because of their superior quality factor (QF) compared to MERV 6, MERV 8, MERV 11 filters, and the EEAF. Combined MERV 8 + MERV 11 filters have the highest QF compared to MERV 6 + MERV 11 filters and EEAF + MERV 11 filters; regarding 50% of PSE 0.1 - 1.0 $$ {PSE}_{0.1-1.0} $$ as the filtration requirements of two-stage filtration systems, the MERV 8 + MERV 11 filtration system can achieve this value at 1.0 m/s air velocity, while PSE 0.1 - 1.0 $$ {PSE}_{0.1-1.0} $$ values were lower than 50% at 1.5 m/s and 2.0 m/s. EEAF obtained a better PSE 0.3 - 1.0 $$ {PSE}_{0.3-1.0} $$ in the full-recirculated test rig than in the single-pass mode owing to active ionization effects when EEAF was charged by alternating current.


Subject(s)
Air Filters , Air Pollution, Indoor , COVID-19 , Air Conditioning , Air Pollution, Indoor/analysis , Filtration , Heating , Humans , Pandemics , Respiration , Ventilation
4.
IEEE J Biomed Health Inform ; 26(1): 172-182, 2022 01.
Article in English | MEDLINE | ID: covidwho-1642566

ABSTRACT

Till March 31st, 2021, the coronavirus disease 2019 (COVID-19) had reportedly infected more than 127 million people and caused over 2.5 million deaths worldwide. Timely diagnosis of COVID-19 is crucial for management of individual patients as well as containment of the highly contagious disease. Having realized the clinical value of non-contrast chest computed tomography (CT) for diagnosis of COVID-19, deep learning (DL) based automated methods have been proposed to aid the radiologists in reading the huge quantities of CT exams as a result of the pandemic. In this work, we address an overlooked problem for training deep convolutional neural networks for COVID-19 classification using real-world multi-source data, namely, the data source bias problem. The data source bias problem refers to the situation in which certain sources of data comprise only a single class of data, and training with such source-biased data may make the DL models learn to distinguish data sources instead of COVID-19. To overcome this problem, we propose MIx-aNd-Interpolate (MINI), a conceptually simple, easy-to-implement, efficient yet effective training strategy. The proposed MINI approach generates volumes of the absent class by combining the samples collected from different hospitals, which enlarges the sample space of the original source-biased dataset. Experimental results on a large collection of real patient data (1,221 COVID-19 and 1,520 negative CT images, and the latter consisting of 786 community acquired pneumonia and 734 non-pneumonia) from eight hospitals and health institutions show that: 1) MINI can improve COVID-19 classification performance upon the baseline (which does not deal with the source bias), and 2) MINI is superior to competing methods in terms of the extent of improvement.


Subject(s)
COVID-19 , Deep Learning , Algorithms , Humans , Pandemics , SARS-CoV-2
5.
IEEE J Biomed Health Inform ; 24(10): 2787-2797, 2020 10.
Article in English | MEDLINE | ID: covidwho-724919

ABSTRACT

Coronavirus Disease 2019 (COVID-19) has rapidly spread worldwide since first reported. Timely diagnosis of COVID-19 is crucial both for disease control and patient care. Non-contrast thoracic computed tomography (CT) has been identified as an effective tool for the diagnosis, yet the disease outbreak has placed tremendous pressure on radiologists for reading the exams and may potentially lead to fatigue-related mis-diagnosis. Reliable automatic classification algorithms can be really helpful; however, they usually require a considerable number of COVID-19 cases for training, which is difficult to acquire in a timely manner. Meanwhile, how to effectively utilize the existing archive of non-COVID-19 data (the negative samples) in the presence of severe class imbalance is another challenge. In addition, the sudden disease outbreak necessitates fast algorithm development. In this work, we propose a novel approach for effective and efficient training of COVID-19 classification networks using a small number of COVID-19 CT exams and an archive of negative samples. Concretely, a novel self-supervised learning method is proposed to extract features from the COVID-19 and negative samples. Then, two kinds of soft-labels ('difficulty' and 'diversity') are generated for the negative samples by computing the earth mover's distances between the features of the negative and COVID-19 samples, from which data 'values' of the negative samples can be assessed. A pre-set number of negative samples are selected accordingly and fed to the neural network for training. Experimental results show that our approach can achieve superior performance using about half of the negative samples, substantially reducing model training time.


Subject(s)
Betacoronavirus , Clinical Laboratory Techniques/statistics & numerical data , Coronavirus Infections/diagnostic imaging , Coronavirus Infections/diagnosis , Pandemics , Pneumonia, Viral/diagnostic imaging , Pneumonia, Viral/diagnosis , Radiographic Image Interpretation, Computer-Assisted/statistics & numerical data , Supervised Machine Learning , Tomography, X-Ray Computed/statistics & numerical data , Algorithms , COVID-19 , COVID-19 Testing , Cohort Studies , Computational Biology , Coronavirus Infections/classification , Deep Learning , Diagnostic Errors/statistics & numerical data , Humans , Neural Networks, Computer , Pandemics/classification , Pneumonia, Viral/classification , Retrospective Studies , SARS-CoV-2
6.
Aging Cell ; 19(7)2020 07.
Article in English | MEDLINE | ID: covidwho-608386

ABSTRACT

The COVID-19 coronavirus is now spreading worldwide. Its pathogen, SARS-CoV-2, has been shown to use angiotensin-converting enzyme 2 (ACE2) as its host cell receptor, same as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003. Epidemiology studies found males although only slightly more likely to be infected than females account for the majority of the severely ill and fatality, which also bias for people older than 60 years or with metabolic and cardiovascular diseases. Here by analyzing GTEx and other public data in 30 tissues across thousands of individuals, we found a significantly higher level in Asian females, an age-dependent decrease in all ethnic groups, and a highly significant decrease in type II diabetic patients of ACE2 expression. Consistently, the most significant expression quantitative loci (eQTLs) contributing to high ACE2 expression are close to 100% in East Asians, >30% higher than other ethnic groups. A shockingly common enrichment of viral infection pathways was found among ACE2 anti-expressed genes, and multiple binding sites of virus infection related transcription factors and sex hormone receptors locate at ACE2 regulatory regions. Human and mice data analysis further revealed ACE2 expression is reduced in T2D patients and with inflammatory cytokine treatment and upregulated by estrogen and androgen (both decrease with age). Our findings revealed a negative correlation between ACE2 expression and COVID-19 fatality at both population and molecular levels. These results will be instrumental when designing potential prevention and treatment strategies for ACE2 binding coronaviruses in general.


Subject(s)
Betacoronavirus/metabolism , Coronavirus Infections/genetics , Coronavirus Infections/virology , Gene Expression Regulation , Genetic Variation/genetics , Peptidyl-Dipeptidase A/genetics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/genetics , Pneumonia, Viral/virology , Angiotensin-Converting Enzyme 2 , Betacoronavirus/pathogenicity , COVID-19 , Computational Biology , Female , Humans , Male , Pandemics , Receptors, Virus/genetics , Receptors, Virus/metabolism , SARS-CoV-2 , Testis/metabolism , Testis/virology
SELECTION OF CITATIONS
SEARCH DETAIL